Greenleaf Trust Alnylam Pharmaceuticals, Inc. Transaction History

Greenleaf Trust

$10.7 Billion
Q1 2024

A detailed history of Greenleaf Trust transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Greenleaf Trust holds 2,863 shares of ALNY stock, worth $718,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,863

Previous 2,938 2.55%

Holding current value

$718,698

Previous $562,000 24.02%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$146.51 - $198.2 $10,988 - $14,865	-75 Reduced 2.55%	2,863 $427,000
Q4 2023 Jan 31, 2024	BUY	$151.41 - $196.57 $61,321 - $79,610	405 Added 15.99%	2,938 $562,000
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $15,369 - $19,048	-90 Reduced 3.43%	2,533 $448,000
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $25,346 - $29,050	-137 Reduced 4.96%	2,623 $498,000
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $11,142 - $14,367	61 Added 2.26%	2,760 $552,000

Q4 2022 Jan 25, 2023	BUY	$185.53 - $241.31 $4,452 - $5,791	24 Added 0.9%	2,699 $641,000
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $16,347 - $27,376	118 Added 4.61%	2,675 $535,000
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $21,796 - $30,641	181 Added 7.62%	2,557 $373,000
Q1 2022 Apr 27, 2022	SELL	$127.18 - $173.91 $103,142 - $141,041	-811 Reduced 25.45%	2,376 $388,000
Q2 2021 Aug 10, 2021	BUY	$128.63 - $176.89 $5,145 - $7,075	40 Added 1.27%	3,187 $540,000
Q1 2021 Apr 30, 2021	BUY	$126.83 - $175.69 $3,678 - $5,095	29 Added 0.93%	3,147 $444,000
Q4 2020 Feb 08, 2021	SELL	$122.97 - $147.0 $1,598 - $1,911	-13 Reduced 0.42%	3,118 $405,000
Q3 2020 Oct 30, 2020	BUY	$121.19 - $165.49 $3,756 - $5,130	31 Added 1.0%	3,131 $456,000
Q4 2019 Feb 11, 2020	BUY	$74.51 - $124.23 $230,981 - $385,113	3,100 New	3,100 $357,000

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account